| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2023―Nov―13 |
Impact of prior coronavirus disease 2019 infection in females on assisted reproductive outcomes: A systematic review with meta-analysis |
Yiqi Liu, Shen Chen, Mengyi Chen, Chutian Xing, Danjie Su, Lu Fan, et al. (+7) Dingfei Xu, Lifeng Tian, Leizhen Xia, Ke Zhang, Qiongfang Wu, Zheng Fang, Jialyu Huang |
| 2 |
[GO] |
2023―Mai―17 |
Repurposing inhaled ibuprofenate, a non-steroidal anti-inflammatas a potential adjuvant treatment for pneumonia, coronavirus disease 2019-associated acute respiratory distress syndrome and its aetiological agent severe acute respiratory syndrome-coronavirus 2 |
Christian Carlos Zurita-Lizza, Ignacio Rodriguez-Sanchez, Pablo Alexis Doreski |
| 3 |
[GO] |
2023―Mai―09 |
Diving boldly into COVID-19 contaminated wastewater: Eyes at nanotechnology-assisted solutions |
Hussein E. Al-Hazmi, Agata Kot-Wasik, Amirhossein Shokrani, Joanna Majtacz, Vahid Vatanpour, Muhammad Tajammal Munir, et al. (+8) Sajjad Habibzadeh, Aleksander Hejna, Mahnaz Hasanpour, Abbas Mohammadi, Sepideh Ahmadi, Eder C. Lima, Navid Rabiee, Mohammad Reza Saeb |
| 4 |
[GO] |
2023―Mrz―29 |
A20 haploinsufficiency caused by loss-of-function
TNFAIP3
mutation likely leads to progression of antiphospholipid syndrome to marginal zone lymphomas following coronavirus disease 2019 vaccination: A case study |
Jie Li, Xuekun Fu, Haichan Xu, Bowen Li, Liping Nie, Ling Ji, Chao Liang |
| 5 |
[GO] |
2023―Jan―23 |
Blocking the action of NLRP3 inflammasome by inhaled ibuprofenate on pulmonary macrophages infected by SARS-CoV-2 |
Christian Carlos Zurita-Lizza, Ignacio Rodriguez-Sanchez, Pablo Alexis Doreski |
| 6 |
[GO] |
2022―Okt―14 |
Latent infections, coronavirus disease 2019 and psychiatric disorders: The friend of my enemy |
Mirza Ali Mofazzal Jahromi, Mina Sefidfard, Ali Taghipour, Abazar Roustazadeh, Sara Matin, Hamed Mir, et al. (+3) Milad Badri, Fares Bahrami, Amir Abdoli |
| 7 |
[GO] |
2022―Okt―10 |
Immune cells-derived exosomes: A promising strategy for COVID-19 treatment |
Zichen Zhang, Jiangang Long, Lingjie Meng, Zhiwei Yang, Shengli Zhang, Lei Zhang |
| 8 |
[GO] |
2022―Jul―26 |
Plasma cell-free DNA analysis for COVID-19 and beyond |
Jia Ju, Kun Sun |
| 9 |
[GO] |
2022―Jul―17 |
The current status of gene expression profilings in COVID-19 patients |
Mirolyuba Ilieva, Max Tschaikowski, Andrea Vandin, Shizuka Uchida |
| 10 |
[GO] |
2022―Jul―11 |
Earlier detection of SARS-CoV-2 infection by blood RNA signature microfluidics assay |
Antonio Cappuccio, Jennifer Geis, Yongchao Ge, Venugopalan D. Nair, Naveen Ramalingam, Weiguang Mao, et al. (+3) Maria Chikina, Andrew G. Letizia, Stuart C. Sealfon |
| 11 |
[GO] |
2022―Jun―29 |
Pre-existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patients |
Manoj Kumar Pandey |
| 12 |
[GO] |
2022―Jun―22 |
Focusing on the long-term recovery of severe acute respiratory syndrome coronavirus 2 infection: Clinically relevant observations |
Chunxia Wang, Yucai Zhang |
| 13 |
[GO] |
2022―Jun―10 |
A commentary on “PI3K-α/mTOR/BRD4 inhibitor alone or in combination with other anti-virals blocks replication of SARS-CoV-2 and its variants of concern including Delta and Omicron” |
Sakthijothi Muthu, Sundararajan Venkatesh |
| 14 |
[GO] |
2022―Jun―05 |
Higher BCG-induced trained immunity prevalence predicts protection from COVID-19: Implications for ongoing BCG trials |
Samer Singh, Dhiraj Kishore, Rakesh K. Singh, Chandramani Pathak, Kishu Ranjan |
| 15 |
[GO] |
2022―Jun―02 |
Early innate immune responses in different COVID-19 sub-phenotypes through a transcriptomics lens |
Wei Yang |
| 16 |
[GO] |
2022―Mai―23 |
Promoting autophagy to mitigate coronavirus disease pathology in the elderly |
Abby Lund Da Costa, Het Mehta, Ramkumar Mathur |
| 17 |
[GO] |
2022―Mai―06 |
Combining antiviral drugs with BET inhibitors is beneficial in combatting SARS-CoV-2 infection |
Arpan Acharya, Tatiana G. Kutateladze, Siddappa N. Byrareddy |
| 18 |
[GO] |
2022―Apr―29 |
Preparedness for further boosting coronavirus disease 2019 vaccines |
So Yun Lim, Jiwon Jung, Sung-Han Kim |
| 19 |
[GO] |
2022―Mrz―05 |
The updated strategy to overcome new challenge: Omicron variant (B.1.1.529) pandemic |
HyokJu Ri, Xin Chen |
| 20 |
[GO] |
2022―Feb―25 |
The risk-benefit ratio of Covid-19 vaccines: Publication policy by retraction does nothing to improve it |
Harald Walach, Rainer J. Klement, Wouter Aukema |
| 21 |
[GO] |
2022―Feb―20 |
Potential reversal of pulmonary vasoplegia by inhaled ibuprofenate in COVID-19 pneumonia |
Christian Carlos Zurita-Lizza, Pablo Alexis Doreski |
| 22 |
[GO] |
2022―Jan―18 |
Dominant mutations in the severe acute respiratory syndrome coronavirus-2 genome challenge polymerase chain reaction detection |
Teng Liu, Leshan Xiu, Kun Yin, Shengli Li |
| 23 |
[GO] |
2022―Jan―13 |
Successful treatment of an 82-year-old COVID-19 delta variant-infected patient with haemorrhagic stroke and active prostate cancer brain metastasis |
Buhai Wang, Jiangquan Yu, Yichun Zeng, Xian Zhang, Chongxu Han, Qili Lu, et al. (+4) Xiaolin Wang, Yichen Liang, Juan J. Gu, Yusheng Shu |
| 24 |
[GO] |
2021―Dez―12 |
How to translate the knowledge of COVID-19 into prevention of Omicron variants |
Xiangdong Wang, Charles A. Powell |
| 25 |
[GO] |
2021―Okt―20 |
A call for discovery: Re-envisioning The Cancer Genome Atlas as a blueprint for a TCGA2.0-The COVID-19 Genome Atlas |
Kristian M. Hargadon |
